Delisting

Tritium Receives Nasdaq Delisting Determination

Retrieved on: 
Thursday, March 21, 2024

BRISBANE, Australia, March 21, 2024 (GLOBE NEWSWIRE) -- Tritium DCFC Limited (Nasdaq: DCFC) (“Tritium” or the “Company”), a global developer and manufacturer of direct current (“DC”) fast chargers for electric vehicles (“EVs”), today announced that on March 15, 2024 the Company received a delisting determination notice (the “Delisting Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”).

Key Points: 
  • BRISBANE, Australia, March 21, 2024 (GLOBE NEWSWIRE) -- Tritium DCFC Limited (Nasdaq: DCFC) (“Tritium” or the “Company”), a global developer and manufacturer of direct current (“DC”) fast chargers for electric vehicles (“EVs”), today announced that on March 15, 2024 the Company received a delisting determination notice (the “Delisting Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”).
  • In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we were provided a period of 180 calendar days, or until April 9, 2024, to regain compliance with the Minimum Bid Price Requirement.
  • On March 15, 2024, the Company received the subsequent Delisting Notice from Nasdaq notifying the Company that, as of March 15, 2024, the Company's ordinary shares had a closing bid price of $0.10 or less for ten consecutive trading days and that, consistent with Nasdaq Listing Rule 5810(c)(3)(A)(iii), Nasdaq had determined to begin the process to delist the Company's common stock from the Nasdaq Global Market.
  • On March 22, 2024, the Company intends to submit a request for a hearing before the Nasdaq Hearings Panel to appeal the Delisting Notice.

micromobility.com Inc. to Address Nasdaq Delisting Notice; Postpones Special Meeting and Withdraws Reverse Split Request

Retrieved on: 
Tuesday, December 19, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231219261914/en/
    The Special Meeting was postponed allowing the board of directors of the Company to continue to assess its corporate governance and operational strategy going forward.
  • Accordingly, the Nasdaq Hearings Panel has determined to delist the Company’s shares and warrants from Nasdaq.
  • Nasdaq will complete the delisting by filing a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (“SEC”), following the expiration of relevant appeal periods.
  • The Delisting Letter provides that the Company may request the Nasdaq Listing and Hearing Review Council to review the delisting decision within 15 days from the date of the Delisting Letter.

EQS-News: Silver Lake announces delisting offer for Software AG at €32 per share; shareholders have 4 weeks to tender their shares before Software AG will be a private company

Retrieved on: 
Tuesday, December 26, 2023

Silver Lake announces delisting offer for Software AG at €32 per share; shareholders have 4 weeks to tender their shares before Software AG will be a private company

Key Points: 
  • Silver Lake announces delisting offer for Software AG at €32 per share; shareholders have 4 weeks to tender their shares before Software AG will be a private company
    The issuer is solely responsible for the content of this announcement.
  • Silver Lake announces delisting offer for Software AG at €32 per share; shareholders have 4 weeks to tender their shares before Software AG will be a private company
    18 December 2023 – Silver Lake, the global leader in technology investing, together with Mosel Bidco SE, a holding company controlled by funds managed or advised by Silver Lake (“Silver Lake”), announced today its decision to launch a delisting offer for all outstanding shares of Software AG at a price of EUR 32.00 per share (“Delisting Offer”), following its initial tender offer that closed on 28 September 2023.
  • Silver Lake currently owns 93.3% of Software AG shares.
  • The offer document (in German and a non-binding English translation) and other information pertaining to the public delisting offer will be published on the following website: www.offer-2023.com .

RiskOn International Confirms It Has Appealed Nasdaq’s Delisting Letter

Retrieved on: 
Monday, December 11, 2023

RiskOn International, Inc. (Nasdaq: ROI) (“RiskOn,” or the “Company”), today announced that it filed an appeal to the Delisting Letter (“Letter”) received on December 1, 2023 from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”).

Key Points: 
  • RiskOn International, Inc. (Nasdaq: ROI) (“RiskOn,” or the “Company”), today announced that it filed an appeal to the Delisting Letter (“Letter”) received on December 1, 2023 from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”).
  • The Company submitted a plan of compliance to Nasdaq to regain compliance with the Equity Rule the (“Compliance Plan”), which the Company subsequently revised, detailing the actions the Company would take to regain compliance with the Equity Rule.
  • On December 8, 2023, the Company requested a hearing (the “Hearing”) before the Nasdaq Listing Qualifications Panel (“Panel”) to appeal the determination by the Staff.
  • At the Hearing, the Company must demonstrate its ability to regain compliance with the Equity Rule, as well as its ability to sustain long-term compliance with all applicable maintenance criteria.

Elys Game Technology Announces Decision of Nasdaq Hearings Panel To Delist Common Shares

Retrieved on: 
Monday, October 16, 2023

The Company’s common stock did not maintain a minimum closing bid price of $1.00 (“Minimum Bid Price Requirement”) per share as required by Nasdaq Listing Rule 5550(a)(2).

Key Points: 
  • The Company’s common stock did not maintain a minimum closing bid price of $1.00 (“Minimum Bid Price Requirement”) per share as required by Nasdaq Listing Rule 5550(a)(2).
  • Accordingly, the Nasdaq Hearings Panel has determined to delist the Company’s shares from Nasdaq.
  • The Company acknowledges that the delisting and cessation of trading on Nasdaq could have a material adverse effect on the liquidity and trading price of its common shares.
  • The shares of the Company's common stock will continue to trade under the symbol "ELYS."

Veradigm Inc. Announces Receipt of Nasdaq Stay Extension

Retrieved on: 
Monday, October 9, 2023

Veradigm Inc. (NASDAQ: MDRX) announced today that, on October 6, 2023, it received a notice from Nasdaq indicating that the temporary stay of delisting of the Company’s common stock has been extended pending a hearing before the Nasdaq Hearings Panel (the “Panel”) on November 16, 2023, and the issuance of a final Panel decision.

Key Points: 
  • Veradigm Inc. (NASDAQ: MDRX) announced today that, on October 6, 2023, it received a notice from Nasdaq indicating that the temporary stay of delisting of the Company’s common stock has been extended pending a hearing before the Nasdaq Hearings Panel (the “Panel”) on November 16, 2023, and the issuance of a final Panel decision.
  • Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all periodic reports with the Securities and Exchange Commission (the “SEC”).
  • The Hearing Request had temporarily stayed any suspension or delisting action until October 12, 2023, and requested that the temporary stay be extended until the Panel issues a final decision on the matter.
  • The Company currently expects to file the Form 10-K and Forms 10-Q during the fourth quarter of 2023.

Capstone Green Energy Enters into Transaction Support Agreement with Senior Secured Lender

Retrieved on: 
Thursday, September 28, 2023

Subject to Bankruptcy Court approval, this "new money" financing will provide liquidity to support continued operations during the Chapter 11 process.

Key Points: 
  • Subject to Bankruptcy Court approval, this "new money" financing will provide liquidity to support continued operations during the Chapter 11 process.
  • "The significant agreement and investment of our senior secured lender demonstrates its support of the Company and our long-term strategy," said Mr. Flexon.
  • At the conclusion of the presentation, Capstone management will conduct a question and answer session to allow financial analysts the chance to ask questions.
  • In addition, Capstone will be offering an opportunity for the broader audience to submit their questions online while the broadcast is live.

Cian Announces Filing of Form 15F to Deregister With the U.S. Securities and Exchange Commission

Retrieved on: 
Wednesday, September 20, 2023

Following the filing of the Form 15F with the SEC, all the Company’s reporting obligations under the Exchange Act will be suspended unless the Form 15F is subsequently withdrawn or denied.

Key Points: 
  • Following the filing of the Form 15F with the SEC, all the Company’s reporting obligations under the Exchange Act will be suspended unless the Form 15F is subsequently withdrawn or denied.
  • Deregistration with the SEC and termination of the Company’s reporting obligations under the Exchange Act (collectively, the “Deregistration”) are expected to become effective 90 days after its filing of Form 15F with the SEC (“Form 15 Effective Date”).
  • Once the Form 15F is filed and before the Form 15F Effective Date, the Company will publish the information required under Rule 12g3‑2(b) of the Exchange Act on its website, https://ir.ciangroup.ru/ .
  • Notwithstanding the Deregistration, the Company currently intends to continue disclosing financial information on a regular basis subject to applicable laws and regulations.

Quarterly Activities and Cashflow Report

Retrieved on: 
Monday, July 31, 2023

On 28 April 2023, Bionomics released its Appendix 4C – Quarterly Cashflow Report for the quarter ended 31 March 2023.

Key Points: 
  • On 28 April 2023, Bionomics released its Appendix 4C – Quarterly Cashflow Report for the quarter ended 31 March 2023.
  • Bionomics may determine to sell some, all, or none of the ADSs under the ATM Program and may terminate the ATM Program at its discretion.
  • Start-up activities for a planned Phase 3 trial of BNC210 in SAD are underway.
  • A copy of the full release, including a copy of the ASX Appendix 4C Cashflow Report can be found on the Company's website.

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

Retrieved on: 
Monday, July 10, 2023

(NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company"), announced today that its board of directors (“Board”) has approved the voluntarily delisting of the Company’s common shares (“Shares”) from the Toronto Stock Exchange (the “TSX”) (the “Delisting”).

Key Points: 
  • (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company"), announced today that its board of directors (“Board”) has approved the voluntarily delisting of the Company’s common shares (“Shares”) from the Toronto Stock Exchange (the “TSX”) (the “Delisting”).
  • The Shares are currently listed on the NASDAQ and the Tel Aviv Stock Exchange, in addition to them being listed on the TSX.
  • Most brokers in Canada, including discount and online brokers, have the ability to buy and sell securities listed on the NASDAQ.
  • Therefore, the Company’s NASDAQ listing will continue to provide shareholders with the same accessibility to trade the Company’s common shares.